Peripheral G-CSF-mobilized blood stem cells (PBSC), use as alternative to marrow stem cells (MSC), is associated with enhanced engraftment and accelerated hematopoietic recovery after allo-SCT. However, despite an increased number of donor T cells infused, the incidence of acute GVHD with PBSC appears to remain identical or less than with MSC. Recent works on the heterogeneity of the human CD4+ and CD8+ T cells have individualized 4 subsets: namely, naive (CCR7+CD45RA+), central memory (TCM, CCR7+CD45RA), effector memory (TEM, CCR7CD45RA), and CD45RA+ effector memory cells (TEMRA, CCR7CD45RA+). To our knowledge, the T cell subsets proportions in MSC and PBCSP grafts remain unknown. The impact of the infused T cell subsets on patients’ outcome is still to be investigated. Between September 2003 and July 2004, 25 consecutive hematopoietic allo-SCT (12 MSC and 13 PBSC) were considered for this study. Multiple combinations of immunophenotyping analysis were used to prospectively examine immune parameters related to graft as well as to early reconstitution. Early post-transplant complications including acute GVHD, relapse and infections were assessed. As expected, T cells subsets, B cells and NK cells numbers were significantly higher in PBSC grafts (versus MSC). However, proportions of CD4+ and CD8+ T-cell subsets were comparable in the 2 types of graft and similar to normal values observed with peripheral blood of healthy adults. Table below summarize the distribution of T cell subsets within T CD4+ and T CD8+ in the two types of graft. The incidence of acute GVHD was significantly higher in pts receiving > 5% of CD8+ TEM cells among infused CD8+ cells (p<0.05) suggesting a detrimental role of this CD8+ subset. Pts who developed acute GVHD, compared to those who did not, had a faster expansion of CD4+ and CD8+ TEM cells (p<0.003), and CD8+ TEMRA cells (p<0.05) after transplantation. Conclusion: this report contributes to the establishment of reference values regarding the distribution of T cell subsets within PBSC and MSC graft. Although, the quantity of infused T cell does not seem to influence early complications after allo-SCT, the qualitative composition of graft regarding T cell subsets, appears to be of great importance in acute GVHD occurrence.

MSCPBSC
CD4+ naive 45% 48% 
CD4+ TCM 25% 24% 
CD4+ TEM 20% 16% 
CD4+ TEMRA 5% 2% 
CD8+ naive 40% 50% 
CD8+ TCM 4% 7% 
CD8+ TEM 23% 14% 
CD8+ TEMRA 29% 22% 
MSCPBSC
CD4+ naive 45% 48% 
CD4+ TCM 25% 24% 
CD4+ TEM 20% 16% 
CD4+ TEMRA 5% 2% 
CD8+ naive 40% 50% 
CD8+ TCM 4% 7% 
CD8+ TEM 23% 14% 
CD8+ TEMRA 29% 22% 

Author notes

Corresponding author

Sign in via your Institution